Balance Sheet: Assets
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.
Paying user area
Try for free
Pfizer Inc. pages available for free this week:
- Common-Size Balance Sheet: Assets
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Price to FCFE (P/FCFE)
- Present Value of Free Cash Flow to Equity (FCFE)
- Return on Assets (ROA) since 2005
- Total Asset Turnover since 2005
- Price to Book Value (P/BV) since 2005
- Analysis of Revenues
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Pfizer Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Pfizer Inc., consolidated balance sheet: assets (quarterly data)
US$ in millions
Based on: 10-Q (reporting date: 2026-06-28), 10-Q (reporting date: 2026-03-29), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-28), 10-Q (reporting date: 2025-06-29), 10-Q (reporting date: 2025-03-30), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-29), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-10-01), 10-Q (reporting date: 2023-07-02), 10-Q (reporting date: 2023-04-02), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-02), 10-Q (reporting date: 2022-07-03), 10-Q (reporting date: 2022-04-03), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-03), 10-Q (reporting date: 2021-07-04), 10-Q (reporting date: 2021-04-04).
Total assets exhibited a growth trajectory from April 2021, rising from 158.8 billion US$ to a peak of 226.5 billion US$ in December 2023. Following this peak, a gradual contraction is observed, with total assets declining to 201.1 billion US$ by June 2026. This pattern indicates a period of significant asset accumulation followed by a phase of balance sheet stabilization or divestment.
- Liquidity and Short-Term Asset Trends
- Current assets showed substantial volatility, reaching a maximum of 74 billion US$ in July 2023. A critical shift occurred between October and December 2023, characterized by a sharp reduction in short-term investments from 41 billion US$ to 9.8 billion US$. Cash and cash equivalents also experienced fluctuations, maintaining a relatively low baseline compared to the volatility seen in short-term investment vehicles.
- Strategic Capital Deployment and Intangibles
- A significant increase in noncurrent assets is evident starting in December 2023. Identifiable intangible assets surged from 40.2 billion US$ in October 2023 to 64.9 billion US$ in December 2023, while goodwill rose from 51.5 billion US$ to 67.8 billion US$ in the same period. This simultaneous spike in intangibles and goodwill, paired with the depletion of short-term investments, indicates a large-scale acquisition or strategic merger during the final quarter of 2023.
- Long-Term Investment and Fixed Asset Evolution
- Long-term investments underwent a dramatic reduction, falling from 14.2 billion US$ in October 2023 to 15.4 billion US$ in December 2023 and then plummeting to 2.2 billion US$ by December 2024, remaining low through 2026. Conversely, property, plant, and equipment (net) demonstrated a steady upward trend, growing from 14.0 billion US$ in 2021 to 19.0 billion US$ by June 2026, suggesting consistent capital expenditure in physical infrastructure.
- Operational Asset Stability
- Trade accounts receivable and inventories remained relatively stable over the analyzed period. Inventories grew moderately from 8.5 billion US$ in early 2021 to a peak of 11.7 billion US$ in September 2024 before settling at 9.9 billion US$ by June 2026. Trade receivables fluctuated within a range of 9.8 billion US$ to 16.1 billion US$, indicating consistent operational scaling relative to revenue cycles.
- Tax Asset Dynamics
- Noncurrent deferred tax assets and other noncurrent tax assets showed a long-term increasing trend, rising from 2.5 billion US$ in April 2021 to 10.8 billion US$ by June 2026, despite a temporary dip in December 2023. This suggests an accumulation of future tax benefits or changes in tax jurisdictions and obligations over time.